Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-22-013724
Filing Date
2022-05-06
Accepted
2022-05-06 18:52:42
Documents
2
Period of Report
2022-05-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5792
2 POWER OF ATTORNEY (PUBLIC): POALOFTON doc1.txt EX-24 3051
  Complete submission text file 0001127602-22-013724.txt   10288
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Lofton Kevin E (Reporting) CIK: 0001468818 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 22902789